These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 12600650)
1. Clinical and virological aspects of hepatitis B co-infection in individuals infected with human immunodeficiency virus type-1. Cooley L; Sasadeusz J J Clin Virol; 2003 Feb; 26(2):185-93. PubMed ID: 12600650 [TBL] [Abstract][Full Text] [Related]
2. [Hepatitis B in patients with HIV infection]. Barreiro P; Martín-Carbonero L; García-Samaniego J Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():71-9. PubMed ID: 19100234 [TBL] [Abstract][Full Text] [Related]
3. Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia. Belyhun Y; Liebert UG; Maier M PLoS One; 2018; 13(2):e0191970. PubMed ID: 29408943 [TBL] [Abstract][Full Text] [Related]
4. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients. Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy. Matthews GV; Bartholomeusz A; Locarnini S; Ayres A; Sasaduesz J; Seaberg E; Cooper DA; Lewin S; Dore GJ; Thio CL AIDS; 2006 Apr; 20(6):863-70. PubMed ID: 16549970 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. Puoti M; Airoldi M; Bruno R; Zanini B; Spinetti A; Pezzoli C; Patroni A; Castelli F; Sacchi P; Filice G; Carosi G AIDS Rev; 2002; 4(1):27-35. PubMed ID: 11998781 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in the treatment of HIV/HBV and HIV/HCV co-infection. Masgala A; Bonovas S; Nikolopoulos GK Mini Rev Med Chem; 2012 Aug; 12(9):890-904. PubMed ID: 22530578 [TBL] [Abstract][Full Text] [Related]
8. Virology and clinical sequelae of drug-resistant HBV in HIV-HBV-coinfected patients on highly active antiretroviral therapy. Thio CL Antivir Ther; 2010; 15(3 Pt B):487-91. PubMed ID: 20516569 [TBL] [Abstract][Full Text] [Related]
9. Short-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infections. Sagoe KW; Duedu KO; Ziga F; Agyei AA; Adiku TK; Lartey M; Mingle JA; Arens M Ann Clin Microbiol Antimicrob; 2016 Jun; 15(1):38. PubMed ID: 27251610 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study. Benhamou Y; Bochet M; Thibault V; Calvez V; Fievet MH; Vig P; Gibbs CS; Brosgart C; Fry J; Namini H; Katlama C; Poynard T Lancet; 2001 Sep; 358(9283):718-23. PubMed ID: 11551579 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy. Wongprasit P; Manosuthi W; Kiertiburanakul S; Sungkanuparph S AIDS Patient Care STDS; 2010 Apr; 24(4):205-9. PubMed ID: 20377434 [TBL] [Abstract][Full Text] [Related]
12. Long-term effects of interferon-alpha in five HIV-positive patients with chronic hepatitis B. di Martino V; Lunel F; Cadranel JF; Hoang C; Parlier Y; Le Charpentier Y; Opolon P J Viral Hepat; 1996 Sep; 3(5):253-60. PubMed ID: 8914005 [TBL] [Abstract][Full Text] [Related]
13. Detection of hepatitis B virus variants in HBV monoinfected and HBV/HIV coinfected Iranian patients under lamivudine treatment. Aghasadeghi MR; Bahramali G; Sadat SM; Farahani A; Mohraz M; Davar Siadat S; Mostafavi E; Memarnejadian A; Ardestani MS; Vahabpour R; Saraji AA; Delbaz SA Curr HIV Res; 2011 Jun; 9(4):263-9. PubMed ID: 21671883 [TBL] [Abstract][Full Text] [Related]
14. Evolution of lamivudine-resistant hepatitis B virus and HIV-1 in co-infected individuals: an analysis of the CAESAR study. CAESAR co-ordinating committee. Pillay D; Cane PA; Ratcliffe D; Atkins M; Cooper D AIDS; 2000 Jun; 14(9):1111-6. PubMed ID: 10894274 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine. Santos EA; Sucupira MV; Arabe J; Gomes SA BMC Infect Dis; 2004 Aug; 4():29. PubMed ID: 15339340 [TBL] [Abstract][Full Text] [Related]
16. The risk of adefovir monotherapy in human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infected patients. Gelinck LB; Claas EC; Kroon FP J Hepatol; 2005 Aug; 43(2):360-1; author reply 361. PubMed ID: 15970350 [No Abstract] [Full Text] [Related]
17. Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals. Lee Z; Nishikawa S; Gao S; Eksteen JB; Czub M; Gill MJ; Osiowy C; van der Meer F; van Marle G; Coffin CS PLoS One; 2015; 10(9):e0137568. PubMed ID: 26390290 [TBL] [Abstract][Full Text] [Related]
18. High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China. Jia HH; Li KW; Chen QY; Wang XY; Harrison TJ; Liang SJ; Yang QL; Wang C; Hu LP; Ren CC; Fang ZL Intervirology; 2018; 61(3):123-132. PubMed ID: 30368502 [TBL] [Abstract][Full Text] [Related]